Zheng-Lin, B., Jaeger, E., Eslinger, C., Fragkogianni, S., Jariwala, U., Layng, K. V., … Bekaii-Saab, T. (2025). 279P Transcriptomic analysis of homologous recombination repair (HRR) genes in BRCA1/2 and PALB2 wild-type (wt) metastatic pancreatic cancer (mPC) suggests potential platinum sensitivity. In Annals of Oncology (Vol. 36, pp. S109–S110). Elsevier BV. https://doi.org/10.1016/j.annonc.2025.05.294

Zheng-Lin, B., E. Jaeger, C. Eslinger, S. Fragkogianni, U. Jariwala, K Viets Layng, T. Shibuki, et al. “279P Transcriptomic analysis of homologous recombination repair (HRR) genes in BRCA1/2 and PALB2 wild-type (wt) metastatic pancreatic cancer (mPC) suggests potential platinum sensitivity.” In Annals of Oncology, 36:S109–10. Elsevier BV, 2025. https://doi.org/10.1016/j.annonc.2025.05.294.

Zheng-Lin B, Jaeger E, Eslinger C, Fragkogianni S, Jariwala U, Layng KV, et al. 279P Transcriptomic analysis of homologous recombination repair (HRR) genes in BRCA1/2 and PALB2 wild-type (wt) metastatic pancreatic cancer (mPC) suggests potential platinum sensitivity. In: Annals of Oncology. Elsevier BV; 2025. p. S109–10.

Zheng-Lin, B., et al. “279P Transcriptomic analysis of homologous recombination repair (HRR) genes in BRCA1/2 and PALB2 wild-type (wt) metastatic pancreatic cancer (mPC) suggests potential platinum sensitivity.” Annals of Oncology, vol. 36, Elsevier BV, 2025, pp. S109–10. Crossref, doi:10.1016/j.annonc.2025.05.294.

Zheng-Lin B, Jaeger E, Eslinger C, Fragkogianni S, Jariwala U, Layng KV, Shibuki T, Ahn D, Abidoye O, Hoyek C, Pirozzi A, Jones JC, Wu C, Borad MJ, Sonbol MB, Strickler JH, Yoshino T, Ikeda M, Bekaii-Saab T. 279P Transcriptomic analysis of homologous recombination repair (HRR) genes in BRCA1/2 and PALB2 wild-type (wt) metastatic pancreatic cancer (mPC) suggests potential platinum sensitivity. Annals of Oncology. Elsevier BV; 2025. p. S109–S110.